rs724159961
Positions:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_003480.4(MFAP5):c.62G>T(p.Trp21Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,611,808 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000030 ( 0 hom. )
Consequence
MFAP5
NM_003480.4 missense
NM_003480.4 missense
Scores
1
10
8
Clinical Significance
Conservation
PhyloP100: 3.56
Genes affected
MFAP5 (HGNC:29673): (microfibril associated protein 5) This gene encodes a 25-kD microfibril-associated glycoprotein which is a component of microfibrils of the extracellular matrix. The encoded protein promotes attachment of cells to microfibrils via alpha-V-beta-3 integrin. Deficiency of this gene in mice results in neutropenia. Alternate splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant 12-8660895-C-A is Benign according to our data. Variant chr12-8660895-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 162200.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High AC in GnomAd4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MFAP5 | NM_003480.4 | c.62G>T | p.Trp21Leu | missense_variant | 3/10 | ENST00000359478.7 | NP_003471.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MFAP5 | ENST00000359478.7 | c.62G>T | p.Trp21Leu | missense_variant | 3/10 | 1 | NM_003480.4 | ENSP00000352455.2 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152028Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
10
AN:
152028
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251316Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135832
GnomAD3 exomes
AF:
AC:
9
AN:
251316
Hom.:
AF XY:
AC XY:
5
AN XY:
135832
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1459780Hom.: 0 Cov.: 30 AF XY: 0.0000317 AC XY: 23AN XY: 726336
GnomAD4 exome
AF:
AC:
44
AN:
1459780
Hom.:
Cov.:
30
AF XY:
AC XY:
23
AN XY:
726336
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152028Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74244
GnomAD4 genome
AF:
AC:
10
AN:
152028
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74244
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Aortic aneurysm, familial thoracic 9 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 04, 2014 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | This sequence change replaces tryptophan, which is neutral and slightly polar, with leucine, which is neutral and non-polar, at codon 21 of the MFAP5 protein (p.Trp21Leu). This variant is present in population databases (rs724159961, gnomAD 0.09%). This missense change has been observed in individual(s) with thoracic aortic aneurysm and dissection (PMID: 25434006). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 162200). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects MFAP5 function (PMID: 25434006). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 12, 2024 | Variant summary: MFAP5 c.62G>T (p.Trp21Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.4e-05 in 1611808 control chromosomes. The observed variant frequency is approximately 2.68 fold of the estimated maximal expected allele frequency for a pathogenic variant in MFAP5 causing Thoracic Aortic Aneurysms And Dissections phenotype (1.3e-05). c.62G>T has been reported in the literature in the heterozygous state in at least 1 family affected with Thoracic Aortic Aneurysms And Dissections (example, Barbier_2014, Arnaud_2019). At least 1 family showed possible, but not compelling, evidence of segregation (example, Barbier_2014). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function. Fibroblasts from affected individual showed decreased protein levels of MFAP5, as did in vitro experiments in HEK cells (example, Barbier_2014). The following publications have been ascertained in the context of this evaluation (PMID: 30739908, 25434006). ClinVar contains an entry for this variant (Variation ID: 162200). Based on the evidence outlined above, the variant was classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D;.;D;.;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
D;T;.;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;L;.;L;.
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;D;D;D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D;T
Polyphen
P;P;.;.;.;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: 3
Find out detailed SpliceAI scores and Pangolin per-transcript scores at